Revvity | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Agilent USD 1.31B 12M 2025-01
Align Technology USD 848.16M 2.91M 2025-03
Bio Techne USD 249.61M 141K 2024-12
Bio-Rad Laboratories USD 561.7M 47.4M 2025-03
Bruker USD 769.6M 145.9M 2025-03
Celltrion KRW 674.25B 128.01B 2024-09
Charles River Laboratories USD 909.5M 260.74M 2025-03
Cspc Pharmaceutical CNY 5.42B 102.74M 2024-09
Danaher USD 4.46B 655M 2025-03
Dentsply International USD 1.41B 1000K 2024-12
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Edwards Lifesciences USD 1.02B 55.3M 2025-03
Exact Sciences USD 802.8M 786.98M 2025-03
Hologic USD 1.01B 220.3M 2025-03
Illumina USD 929M 590M 2024-12
Intuitive Surgical USD 1.68B 3.3M 2025-03
IQVIA Holdings USD 3.34B 5M 2025-03
Kangmei Pharma CNY 1.46B 193.63M 2024-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 311.35M 170.35M 2024-12
Laboratory Of America USD 3.01B 100.2M 2025-03
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Mettler Toledo International USD 681.8M 48.78M 2025-03
Myriad Genetics USD 224.9M 24.7M 2025-03
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 54.04M 9.62M 2024-12
Pharma Mar EUR 41.94M 1.53M 2025-03
Qiagen NV USD 377.04M 4.6M 2024-12
Quest Diagnostics USD 2.31B 46M 2025-03
Quidel USD 808.2M 96.1M 2024-12
Repligen USD 162.59M 41.45M 2025-03
Revvity USD 592.53M 18.09M 2025-03
Sartorius EUR 745.6M 21.2M 2025-03
Sino Biopharmaceutical CNY 11.66B 5.46B 2024-12
Thermo Fisher Scientific USD 8.65B 731M 2025-03
Tilray USD 253.17M 16.55M 2024-11
Waters USD 509.96M 70.49M 2025-03
Zz Pientze Pharmaceu 1.96B 275.44K 2025-03



Revvity Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.